(RTTNews) - Viridian Therapeutics (VRDN) Monday has granted 113,200 stock options to nine new employees and 310,700 stock options to newly appointed Chief Medical Officer, Dr. Radhika Tripuraneni.

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing ...

It will see the combined company become the largest landholder in Alberta's Montney and Duvernay regions, two of North America’s most important shale plays. Sign up here. The combined company ...

The increase in production was fueled by a drilling technique known as fracking, which forces sand and chemicals down a pipe to free fossil fuels trapped miles underground in shale formations. As ...

China has discovered two major shale oilfields boasting combined reserves of 180 million tonnes, in another boost to the country’s push to reduce its reliance on fossil fuel imports. Sinopec ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Tuesday, shares of Viridian Therapeutics Inc (Symbol: VRDN) entered into oversold territory, hitting an RSI ...

David Howald, Flywheel Energy’s chief operating officer, said that controlling costs, new technology, and industry economics are at the heart of his company investing heavily in the Fayetteville Shale ...

State Key Laboratory of Oil & Gas Reservoir Geology and Exploitation, Southwest Petroleum University, Chengdu, Sichuan 610500, China ...

Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include Cobomarsen ...